Elevated Expression of G3BP1 Associates with YB1 and P-AKT and Predicts Poor Prognosis in Nonsmall Cell Lung Cancer Patients After Surgical Resection

Overview

Journal Cancer Med

Specialty Oncology

Date 2019 Sep 28

PMID 31560169

Citations 25

Authors

Hongmei Zheng

Yuting Zhan

Yuting Zhang

Sile Liu

Junmi Lu

Yang Yang

Qiuyuan Wen

Songqing Fan

Affiliations

Soon will be listed here.

Abstract

Purpose: G3BP1 is an RNA-binding protein and plays roles in regulating signaling pathway. YB-1 is a DNA/RNA binding protein encoded by YBX1 gene. Phosphorylated AKT (p-AKT) acts as a pivotal molecule in PI3K/AKT pathway. YB-1 drives stress granules (SGs) formation by activating G3BP1 translation under diverse conditions. SGs are involved in many different metabolic and signaling pathways which may include PI3K/AKT/mTOR. So far, there has been no report on the relationship between expression of G3BP1, p-AKT, and YB1 and clinicopathological features/prognosis in surgically resected nonsmall cell lung cancer (NSCLC) patients.

Methods: In this study, data from TCGA (The Cancer Genome Atlas) were downloaded to investigate the mRNA expression of G3BP1 and YB1 (YBX1) and their correlation in NSCLC. Also, expression of G3BP1, YB1, and p-AKT proteins was studied using immunohistochemistry in tissue microarrays of NSCLC and in noncancerous lung tissues.

Results: We found that the mRNA expression of G3BP1 and YB1 was higher in NSCLC tissues (both P < .05), and G3BP1 was positively correlated with YB1 in mRNA level (r = .399, P < .001). Also, expression of G3BP1, YB1, and p-AKT proteins was higher in NSCLC tissues (all P < .05). And higher expression of G3BP1 and YB1 proteins was seen in patients with clinical stage II and III compared with stage I (both P < .05). Besides, expression of G3BP1 protein had a positive correlation with YB1 and p-AKT (both P < .05). Moreover, overall survival was shorter in patients with overexpression of G3BP1, YB1, and p-AKT proteins (all P < .05). Multivariate analysis confirmed that overexpression of G3BP1 protein was an independent poorer prognostic factor for NSCLC patients (P = .039).

Conclusion: G3BP1 may play a crucial role in activating PI3K/AKT/mTOR pathway. G3BP1 might be served as a novel prognostic biomarker for surgically resected NSCLC patients, which afforded new insights into the study on the mechanism and therapy of NSCLC.

Citing Articles

A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features.

Quan Z, Fan S, Zheng H, Ning Y, Yang Y Cancer Biol Ther. 2025; 26(1):2458773.

PMID: 39881438 PMC: 11784653. DOI: 10.1080/15384047.2025.2458773.

Deep learning based analysis of G3BP1 protein expression to predict the prognosis of nasopharyngeal carcinoma.

Zhou L, Yang M, Luo J, Zang H, Fan S, Zhan Y PLoS One. 2025; 20(1):e0315893.

PMID: 39869565 PMC: 11771904. DOI: 10.1371/journal.pone.0315893.

Stress granules play a critical role in hexavalent chromium-induced malignancy in a G3BP1 dependent manner.

Shaw B, Thwin P, Jia N, Weng H, Ma C, Zhu H Environ Pollut. 2024; 362:124997.

PMID: 39306064 PMC: 11563910. DOI: 10.1016/j.envpol.2024.124997.

Metal-polyphenol-network coated R612F nanoparticles reduce drug resistance in hepatocellular carcinoma by inhibiting stress granules.

Zhou Y, Zhang T, Wang S, Jiao Z, Lu K, Liu X Cell Death Discov. 2024; 10(1):384.

PMID: 39198406 PMC: 11358291. DOI: 10.1038/s41420-024-02161-6.

G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway.

Zhan Y, Wang W, Wang H, Xu Y, Zhang Y, Ning Y Int J Biol Sci. 2024; 20(1):94-112.

PMID: 38164170 PMC: 10750281. DOI: 10.7150/ijbs.85341.

References

Min L, Ruan Y, Shen Z, Jia D, Wang X, Zhao J . Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients. Histopathology. 2015; 67(5):677-88. DOI: 10.1111/his.12695. View

Detterbeck F, Boffa D, Kim A, Tanoue L . The Eighth Edition Lung Cancer Stage Classification. Chest. 2016; 151(1):193-203. DOI: 10.1016/j.chest.2016.10.010. View

Ferreira G, Germeyer A, de Barros Machado A, do Nascimento T, Strowitzki T, Simoni Brum I . Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin. Eur J Obstet Gynecol Reprod Biol. 2014; 175:157-62. DOI: 10.1016/j.ejogrb.2014.01.009. View

Altomare D, Testa J . Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005; 24(50):7455-64. DOI: 10.1038/sj.onc.1209085. View

Takahashi M, Higuchi M, Matsuki H, Yoshita M, Ohsawa T, Oie M . Stress granules inhibit apoptosis by reducing reactive oxygen species production. Mol Cell Biol. 2012; 33(4):815-29. PMC: 3571346. DOI: 10.1128/MCB.00763-12. View

Barnes C, Li F, Mandal M, Yang Z, Sahin A, Kumar R . Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. Cancer Res. 2002; 62(5):1251-5. View

Somasekharan S, El-Naggar A, Leprivier G, Cheng H, Hajee S, Grunewald T . YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1. J Cell Biol. 2015; 208(7):913-29. PMC: 4384734. DOI: 10.1083/jcb.201411047. View

Tourriere H, Chebli K, Zekri L, Courselaud B, Blanchard J, Bertrand E . The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol. 2003; 160(6):823-31. PMC: 2173781. DOI: 10.1083/jcb.200212128. View

Parker F, Maurier F, Delumeau I, Duchesne M, FAUCHER D, Debussche L . A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol. 1996; 16(6):2561-9. PMC: 231246. DOI: 10.1128/MCB.16.6.2561. View

10.

Li J, Wen Q, Xu L, Wang W, Luo J, Chu S . Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma. Hum Pathol. 2014; 45(12):2447-52. DOI: 10.1016/j.humpath.2014.08.010. View

11.

Balsara B, Pei J, Mitsuuchi Y, Page R, Klein-Szanto A, Wang H . Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis. 2004; 25(11):2053-9. DOI: 10.1093/carcin/bgh226. View

12.

Bansal T, Tanveer N, Singh U, Sharma S, Kaur N . Y-Box binding protein 1 expression in breast cancer and its correlation with hormone receptors and other prognostic markers. J Lab Physicians. 2018; 10(4):420-425. PMC: 6210848. DOI: 10.4103/JLP.JLP_58_18. View

13.

Grille S, Bellacosa A, Upson J, Klein-Szanto A, van Roy F, Lee-Kwon W . The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003; 63(9):2172-8. View

14.

Johnson S, Gulhati P, Rampy B, Han Y, Rychahou P, Doan H . Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg. 2010; 210(5):767-76, 776-8. PMC: 2895913. DOI: 10.1016/j.jamcollsurg.2009.12.008. View

15.

Zhang C, Wang J, Cai M, Shao R, Liu H, Zhao W . The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2018; 27(3):300-305. DOI: 10.1080/1061186X.2018.1523415. View

16.

Lasham A, Print C, Woolley A, Dunn S, Braithwaite A . YB-1: oncoprotein, prognostic marker and therapeutic target?. Biochem J. 2012; 449(1):11-23. DOI: 10.1042/BJ20121323. View

17.

Lyabin D, Eliseeva I, Ovchinnikov L . YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA. 2013; 5(1):95-110. DOI: 10.1002/wrna.1200. View

18.

Spriggs K, Bushell M, Willis A . Translational regulation of gene expression during conditions of cell stress. Mol Cell. 2010; 40(2):228-37. DOI: 10.1016/j.molcel.2010.09.028. View

19.

Miller K, Sauer A, Ortiz A, Fedewa S, Pinheiro P, Tortolero-Luna G . Cancer Statistics for Hispanics/Latinos, 2018. CA Cancer J Clin. 2018; 68(6):425-445. DOI: 10.3322/caac.21494. View

20.

Huang Y, Wernyj R, Norton D, Precht P, Seminario M, Wange R . Modulation of specific protein expression levels by PTEN: identification of AKAP121, DHFR, G3BP, Rap1, and RCC1 as potential targets of PTEN. Oncogene. 2005; 24(23):3819-29. DOI: 10.1038/sj.onc.1208527. View